FDA Approves First Over-the-Counter Acetaminophen and Naproxen Sodium Combination for 12-Hour Pain Relief
The U.S. Food and Drug Administration (FDA) has approved the first over-the-counter combination of acetaminophen (Tylenol) and naproxen sodium. This new medication is designed to provide up to 12 hours of temporary relief for various types of minor aches and…
St. Louis, MO, July 28, 2026 —
The U.S. Food and Drug Administration (FDA) has announced the approval of the first over-the-counter (OTC) medication that combines acetaminophen and naproxen sodium. This new product is intended to offer temporary relief from minor aches and pains for up to 12 hours.
The combination medication is approved for use in adults and children aged 12 years and older. It aims to provide a dual-action approach to pain management by utilizing the properties of both acetaminophen, a common pain reliever and fever reducer, and naproxen sodium, a nonsteroidal anti-inflammatory drug (NSAID) that also reduces pain and inflammation.
This FDA approval marks a significant development in the availability of OTC pain relief options, potentially offering consumers a new choice for managing various types of temporary discomfort. The duration of relief, stated as up to 12 hours, is a key feature highlighted for this new combination product.
Details regarding the specific brand name under which this combination will be available, the pharmaceutical company responsible for its development, and the exact timeline for its market release were not immediately provided in the information available.
Consumers seeking pain relief should consult with a healthcare professional or pharmacist to determine if this new combination medication is appropriate for their individual needs and health conditions. As with any medication, it is important to follow dosage instructions and be aware of potential side effects or interactions.
Story summarized from the original created by Debra Worley on www.firstalert4.com, see more information here.
